Chris Halpin

2.3k total citations
36 papers, 1.5k citations indexed

About

Chris Halpin is a scholar working on Sensory Systems, Epidemiology and Neurology. According to data from OpenAlex, Chris Halpin has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Sensory Systems, 13 papers in Epidemiology and 10 papers in Neurology. Recurrent topics in Chris Halpin's work include Hearing, Cochlea, Tinnitus, Genetics (17 papers), Hearing Loss and Rehabilitation (10 papers) and Meningioma and schwannoma management (10 papers). Chris Halpin is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (17 papers), Hearing Loss and Rehabilitation (10 papers) and Meningioma and schwannoma management (10 papers). Chris Halpin collaborates with scholars based in United States, Australia and Canada. Chris Halpin's co-authors include Steven D. Rauch, Scott R. Plotkin, Fred G. Barker, Rakesh K. Jain, A. Gregory Sorensen, Michael J. McKenna, A. W. R. TYRRELL, Emmanuelle di Tomaso, Anat Stemmer‐Rachamimov and Timothy P. Padera and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Chris Halpin

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Halpin United States 18 825 715 354 313 196 36 1.5k
Quinton Gopen United States 24 593 0.7× 414 0.6× 704 2.0× 914 2.9× 118 0.6× 103 1.9k
Samuel H. Selesnick United States 24 689 0.8× 595 0.8× 229 0.6× 250 0.8× 66 0.3× 84 1.7k
Lukas D. Landegger United States 21 244 0.3× 291 0.4× 528 1.5× 251 0.8× 309 1.6× 58 1.5k
Joni K. Doherty United States 21 358 0.4× 266 0.4× 369 1.0× 293 0.9× 241 1.2× 62 1.4k
A. W. Morrison United Kingdom 23 340 0.4× 344 0.5× 486 1.4× 659 2.1× 58 0.3× 60 1.3k
Ashkan Monfared United States 14 240 0.3× 207 0.3× 205 0.6× 151 0.5× 68 0.3× 48 922
Nicole M. Tombers United States 22 775 0.9× 947 1.3× 267 0.8× 243 0.8× 86 0.4× 53 1.5k
William W. M. Lo United States 22 452 0.5× 284 0.4× 228 0.6× 147 0.5× 103 0.5× 43 1.4k
Lee A. Harker United States 23 296 0.4× 205 0.3× 365 1.0× 481 1.5× 73 0.4× 48 1.4k
Won‐Sang Lee South Korea 17 205 0.2× 140 0.2× 267 0.8× 245 0.8× 58 0.3× 60 768

Countries citing papers authored by Chris Halpin

Since Specialization
Citations

This map shows the geographic impact of Chris Halpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Halpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Halpin more than expected).

Fields of papers citing papers by Chris Halpin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Halpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Halpin. The network helps show where Chris Halpin may publish in the future.

Co-authorship network of co-authors of Chris Halpin

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Halpin. A scholar is included among the top collaborators of Chris Halpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Halpin. Chris Halpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergner, Amanda L., Chris Halpin, Vanessa L. Merker, et al.. (2018). Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2. Otology & Neurotology. 39(5). 632–638. 16 indexed citations
2.
Blakeley, Jaishri O., Xiaobu Ye, Dan G. Duda, et al.. (2016). Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas. Journal of Clinical Oncology. 34(14). 1669–1675. 86 indexed citations
3.
Plotkin, Scott R., Simone Ardern‐Holmes, Fred G. Barker, et al.. (2013). Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology. 81(21_supplement_1). S25–32. 33 indexed citations
4.
Halpin, Chris, Helen Shi, Domenic J. Reda, et al.. (2012). Audiology in the Sudden Hearing Loss Clinical Trial. Otology & Neurotology. 33(6). 907–911. 11 indexed citations
5.
Plotkin, Scott R., Vanessa L. Merker, Chris Halpin, et al.. (2012). Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2. Otology & Neurotology. 33(6). 1046–1052. 167 indexed citations
6.
Halpin, Chris & Steven D. Rauch. (2011). Improvement in Word Recognition Score with Level Is Associated with Hearing Aid Ownership among Patients with Hearing Loss. Audiology and Neurotology. 17(3). 139–147. 8 indexed citations
7.
Cunnane, Mary E., et al.. (2010). Radiologic and Audiologic Evidence of the Location of an Intracochlear Mass. Otology & Neurotology. 32(5). e34–e35. 2 indexed citations
8.
Plotkin, Scott R., Chris Halpin, Michael J. McKenna, et al.. (2010). Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients. Otology & Neurotology. 31(7). 1135–1143. 79 indexed citations
9.
Plotkin, Scott R., Anat Stemmer‐Rachamimov, Fred G. Barker, et al.. (2009). Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2. New England Journal of Medicine. 361(4). 358–367. 325 indexed citations
10.
Plotkin, Scott R., Chris Halpin, Jaishri O. Blakeley, et al.. (2009). Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. Journal of Neuro-Oncology. 93(1). 61–77. 43 indexed citations
11.
Halpin, Chris & Katherine B. Sims. (2008). Twenty years of audiology in a patient with Norrie disease. International Journal of Pediatric Otorhinolaryngology. 72(11). 1705–1710. 16 indexed citations
12.
Plotkin, Scott R., et al.. (2008). Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy. Nature Clinical Practice Oncology. 5(8). 487–491. 44 indexed citations
13.
Halpin, Chris, et al.. (2005). Audiologic Features of Norrie Disease. Annals of Otology Rhinology & Laryngology. 114(7). 533–538. 25 indexed citations
14.
Halpin, Chris & Steven D. Rauch. (2005). Using Audiometric Thresholds and Word Recognition in a Treatment Study. Otology & Neurotology. 27(1). 110–116. 42 indexed citations
15.
Halpin, Chris, et al.. (2003). Oral Steroid Treatment of Sudden Sensorineural Hearing Loss: A Ten Year Retrospective Analysis. Otology & Neurotology. 24(5). 728–733. 146 indexed citations
16.
McKenna, Michael J., Joseph B. Nadol, R. G. Ojemann, & Chris Halpin. (1996). Vestibular neurectomy: retrosigmoid-intracanalicular versus retrolabyrinthine approach.. PubMed. 17(2). 253–8. 17 indexed citations
17.
Cabellos, Carmen, et al.. (1995). The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis. The Pediatric Infectious Disease Journal. 14(2). 93–96. 28 indexed citations
18.
Bhatt, Sunil, Arthur M. Lauretano, Carmen Cabellos, et al.. (1993). Progression of Hearing Loss in Experimental Pneumococcal Meningitis: Correlation with Cerebrospinal Fluid Cytochemistry. The Journal of Infectious Diseases. 167(3). 675–683. 55 indexed citations
19.
Thornton, Aaron R., et al.. (1992). The Effect of Cochlear Hearing Loss on Auditory Brain Stem Response Latency. Ear and Hearing. 13(4). 233–235. 5 indexed citations
20.
Halpin, Chris, et al.. (1991). Hearing loss and pneumococcal meningitis: An animal model. The Laryngoscope. 101(12). 1285–1292. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quinton Gopen Breakdown of academic impact, for papers by Samuel H. Selesnick Breakdown of academic impact, for papers by Lukas D. Landegger Breakdown of academic impact, for papers by Joni K. Doherty Breakdown of academic impact, for papers by A. W. Morrison Breakdown of academic impact, for papers by Ashkan Monfared Breakdown of academic impact, for papers by Nicole M. Tombers Breakdown of academic impact, for papers by William W. M. Lo Breakdown of academic impact, for papers by Lee A. Harker Breakdown of academic impact, for papers by Won‐Sang Lee
Rankless by CCL
2026